HCAT
Health Catalyst, Inc.·Healthcare
1.30
3.175%(+0.04)
Close PriceLast Updated: — ET
52W L: $0.9552W H: $4.29
HCAT NEWS
seekingalpha.com
May 12
Health Catalyst, Inc. (HCAT) Q1 2026 Earnings Call Transcript
Health Catalyst, Inc. (HCAT) Q1 2026 Earnings Call Transcript
marketbeat.com
May 11
Health Catalyst Q1 Earnings Call Highlights
Health Catalyst NASDAQ: HCAT reported first-quarter 2026 results that topped its own expectations, while management outlined a broad restructuring plan aimed at simplifying the company's operating model, reducing costs and shifting the business further toward technology-led growth.
zacks.com
May 11
Health Catalyst (HCAT) Q1 Earnings and Revenues Surpass Estimates
Health Catalyst (HCAT) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to earnings of $0.01 per share a year ago.
zacks.com
May 11
Compared to Estimates, Health Catalyst (HCAT) Q1 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Health Catalyst (HCAT) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
globenewswire.com
May 11
Health Catalyst Reports First Quarter 2026 Results
SALT LAKE CITY, May 11, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today reported financial results for the quarter ended March 31, 2026. “We delivered solid first quarter results, with revenue and adjusted EBITDA exceeding expectations,” said Ben Albert, Chief Executive Officer of Health Catalyst.
zacks.com
May 7
Seeking Clues to Health Catalyst (HCAT) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics
Evaluate the expected performance of Health Catalyst (HCAT) for the quarter ended March 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
